{"pub_date": "2016-10-01T04:00:00+0000", "subsection_name": null, "lead_paragraph": "The Securities and Exchange Commission said the company disguised bribes to foreign officials as legitimate travel, entertainment and marketing expenses.", "print_page": null, "document_type": "article", "byline": {"contributor": "", "person": [], "original": "By REUTERS", "organization": "REUTERS"}, "multimedia": [], "section_name": "Business Day", "headline": {"main": "Glaxo to Pay $20 Million to Settle U.S. Bribery Case in China"}, "source": "The New York Times", "blog": [], "word_count": "261", "web_url": "http://www.nytimes.com/2016/10/01/business/glaxo-to-pay-20-million-to-settle-us-bribery-case-in-china.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The Securities and Exchange Commission said the company disguised bribes to foreign officials as legitimate travel, entertainment and marketing expenses....", "_id": "57eeca2d95d0e021d79896ee", "abstract": null, "keywords": [{"rank": "1", "name": "organizations", "value": "GlaxoSmithKline PLC", "is_major": "N"}, {"rank": "2", "name": "subject", "value": "Bribery and Kickbacks", "is_major": "N"}, {"rank": "3", "name": "subject", "value": "Foreign Corrupt Practices Act (1977)", "is_major": "N"}, {"rank": "4", "name": "organizations", "value": "Securities and Exchange Commission", "is_major": "N"}, {"rank": "5", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}, {"rank": "6", "name": "glocations", "value": "China", "is_major": "N"}]}